Skip to main content
AUPH filings

Corporate insider profile

Kevin Tang Filing Activity

Latest reported as Chief Executive Officer of Aurinia Pharmaceuticals Inc. (AUPH).

Purchase filings
1
Reported companies
1
Net open-market value
$12,455,244
Latest transaction
Jun 2, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 2, 2026Aurinia Pharmaceuticals Inc. (AUPH)Chief Executive OfficerOpen Market Purchase814,606$15.29$12,455,244